Bluu Biosciences Revenue and Competitors

Berlin, Germany

Location

#7715

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Bluu Biosciences's estimated annual revenue is currently $10.8M per year.(i)
  • Bluu Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Bluu Biosciences has 70 Employees.(i)
  • Bluu Biosciences grew their employee count by 56% last year.

Bluu Biosciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Finance & AdministrationReveal Email/Phone
3
Associate Director Cell Culture and Media DevelopmentReveal Email/Phone
4
Quality and Regulatory ManagerReveal Email/Phone
5
Research AssistantReveal Email/Phone
6
Scientist Process DevelopmentReveal Email/Phone
7
WissenschaftlerinReveal Email/Phone
8
Research Assistant Bioprocess DevelopmentReveal Email/Phone
9
HR-ManagerReveal Email/Phone
10
Marketing & CommunicationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$36.9M2389%N/AN/A
#2
$33.7M174-10%$521.9MN/A
#3
$52.4M33815%N/AN/A
#4
$162.7M121933%N/AN/A
#5
$43.2M2797%N/AN/A
#6
$1.1M7N/AN/AN/A
#7
$24.2M15610%N/AN/A
#8
$19.7M1278%N/AN/A
#9
$21.2M13712%$347.1MN/A
#10
$18.3M1187%$197.4MN/A
Add Company

What Is Bluu Biosciences?

Creating the future of healthy seafood — made from fish cells.

keywords:N/A

N/A

Total Funding

70

Number of Employees

$10.8M

Revenue (est)

56%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bluu Biosciences News

2022-04-06 - Bluu Seafood and CellX Partner to "Make Cellular Agriculture ...

Bluu Seafood (formerly Bluu Biosciences), which claims to be the first European company specializing in cultivated fish, will present its...

2022-04-06 - Bluu Seafood And CellX Announce Cross-Continental ...

Bluu Seafood, formerly Bluu Biosciences, is the first European startup to be exclusively targeting cultivated fish. The company aims to have...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.4M70-16%N/A
#2
$9.1M70-31%N/A
#3
$8.2M70N/AN/A
#4
$20.8M70-5%N/A
#5
$17M7017%N/A